Challenges in screening for depression in multiple sclerosis

Multiple Sclerosis

Volumn 16, Issue 11, 2010, Pages 1406-1411

  Patten, Scott B ^a   Berzins, Sandy ^b   Metz, Luanne M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Depression; multiple sclerosis; psychiatric status rating scales; screening

Indexed keywords

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL ASSESSMENT; DEPRESSION; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIPLE SCLEROSIS; PATIENT CARE; PROSPECTIVE STUDY; RATING SCALE; SCREENING;

ADULT; DEPRESSION; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; MULTIPLE SCLEROSIS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES;

EID: 78449301400     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510377770     Document Type: Article

References (25)

1. The Goldman Consensus Conference Participants, National MS Society. The Goldman Consensus Statement on Mood Disorders in Multiple Sclerosis. Mult Scler 2005 ; 11: 328-337.
2. Patten SB, Beck CA, Williams JVA, Barbui C. and Metz L. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003 ; 61: 1524-1527.
3. Minden SL, Orav J. and Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry 1987 ; 9: 426-434.
4. Sadovnick AD, Remick RA, Allen J., Swartz E., Yee IML, Eisen K., et al. Depression and multiple sclerosis. Neurology 1996 ; 46: 628-632.
5. Joffe RT, Lippert GP, Gray TA, Sawa G. and Horvath Z. Mood disorders and multiple sclerosis. Arch Neurol 1987 ; 44: 376-378.
6. Sadovnick AD, Eisen K., Ebers GC and Paty DW Cause of death in patients attending multiple sclerosis clinics. Neurology 1991 ; 41: 1193-1196.
7. Hansen H., Stenager E., Stenager EN and Koch-Henriksen N. Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005 ; 76: 1457-1459.
8. Koch-Henriksen N., Bronnum-Hansen H. and Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry 1998 ; 65: 56-59.
9. Stenager EN, Stenager E., Koch-Henriksen N., Bronnum-Hansen H., Hyllested K., Jensen K., et al. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 1992 ; 55: 542-545.
10. Mohr DC, Goodkin DE, Likosky W., Gatto N., Baumann KA and Rudick RA Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997 ; 54: 531-533.
11. Mohr DC, Goodkin DE, Islar J., Hauser SL and Genain CP Treatment of depression is associated with suppression of nonspecific and antigen-specific T-H1 responses in multiple sclerosis. Arch Neurol 2001 ; 58: 1081-1086.
12. Schiffer RB and Wineman NM Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 1990 ; 147: 1493-1497.
13. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A. and Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Cons Clin Psychol 2001 ; 69: 942-949.
14. Ehde DM, Kraft GH, Chwastiak L., Sullivan MD, Gibbons LE, Bombardier CH, et al. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. Gen Hosp Psychiatry 2008 ; 30: 40-48.
15. Rothman KJ Epidemiology. An Introduction. Oxford: Oxford University Press, 2002.
16. Patten SB, Newman S., Becker M., Riddell C. and Metz L. Disease management for depression in an MS clinic. Int J Psychiatry Med 2007 ; 37: 459-473.
17. Sollom AC and Kneebone II Treatment of depression in people who have multiple sclerosis. Mult Scler 2007 ; 13: 632-635.
18. Patten SB, Williams JV and Metz L. Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis. Mult Scler 2008 ; 14: 406-411.
19. Patten SB, Lavorato DH and Metz LM Clinical correlates of CES-D depressive symptom ratings in an MS population. Gen Hosp Psychiatry 2005 Nov; 27 (6). 439-445.
20. Radloff LS The CES-D scale: a self-report depression scale for research in the general population. Applied Psychol Measurement 1977 ; 1: 385-401.
21. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an Dxpanded Disability Status Scale (EDSS). Neurology 1983 ; 33: 1444-1452.
22. Stata [computer program]. Version 9.0. College Station. TX: Stata Corporation, 2005.
23. Chwastiak L., Ehde DM, Gibbons LE, Sullivan M., Bowen JD and Kraft GH Depressive symptoms and severity of illness in multiple sclerosis: epidemiological study of a large community sample. Am J Psychiatry 2002 ; 159: 1862-1868.
24. Patten SB, Metz LM and Reimer MA Biopsychosocial correlates of major depression in a multiple sclerosis population. Mult Scler 2000 ; 6: 115-120.
25. Gilbody S., Sheldon T. and Wessely S. Should we screen for depression? BMJ 2006 Apr 29; 332 (7548). 1027-1030.